A First in Human Study of STT-5058, an Antibody That Binds ApoC3

NCT04419688 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
93
Enrollment
INDUSTRY
Sponsor class

Stopped recruitment failure

Conditions

Interventions

Sponsor

Staten Biotechnology BV